Back to top
Back to top

Raised to Date
$7,313
35 Investors Interested

73%
Pledged:
ID:
TRU-XLH-2023
Exemption:
REG-CF
Issue Type:
TBD
Accredited Only:
No
Reviewed Financials:
Yes
Reviewed By:
Price per Share:
$7.10
Minimum Investment:
$142
Requested Investment:
$142
Investment Increments:
$71
Minimum Goal:
$10,000
Stretch Goal:
$10,000
Maximum Goal:
$1,234,995
Raise Start Date:
February 28th, 2023
Raise Target Date:
March 19th, 2025
Raise End Date:
March 19th, 2025

Offering Overview

Little Dragon: AI Budtender

Our mission is to take the guesswork out of cannabis product selection and revolutionize the retail experience with data-driven personalization. Even the savviest cannabis enthusiasts face challenges with the myriad of products in the market, but the era of conjecture and inconsistent experiences is over. Little Dragon’s technology will redefine how people shop for cannabis. This isn't just a recommendation generator; it's an intelligent guide, leading customers to confident purchases, simplifying product selection, and evolving with each interaction. This commitment to personalization mirrors the online shopping revolution led by giants like Amazon.

Problem

Have you ever consumed an indica product, hoping to unwind but instead felt energetic, hyper-focused, or even paranoid? Or experimented with a hybrid/sativa before attempting some creative work but found yourself passed out for 4 hours?

That’s because strain names and indica/sativa labels don’t give us the information we need to make an informed purchase about how a specific product will affect us. The same cannabis product can have different effects on different people due to the complex nature of human physiology.


The end result? Consumers often face unpredictability in the effects they receive from cannabis, leading to a mismatch between expectation and experience.
 

Solution

We believe personalized wellness is the future of this industry, so we set out to change the way you shop for cannabis entirely! Little DragonTM: AI Budtender is your own cannabis sommelier, providing you with the most individually tailored shopping experience.

Our technology is built on a foundation of plant science, using lab data to inform recommendations and integrating user feedback to evolve with your preferences over time. 

We harness the power of Generative AI to predict and align product effects with consumer expectations and enhance reliability and satisfaction in cannabis use. 

Achievement & Traction

Value Proposition 
The Company's AI Budtender Platform provides personalized product recommendations to consumers purchasing cannabis online from licensed dispensaries. These recommendations are derived from a sophisticated analysis of plant science, customer feedback, and generative AI.

The integration of Little Dragon’s AI Budtender API to a dispensary’s online sales platform offers significant benefits to the dispensary by enhancing customer retention and satisfaction, creating a self-sustaining base of loyal customers.

Market

In a market poised for transformation, Time magazine and Forbes have spotlighted generative AI's disruptive potential in personalizing medical data. Cannabis, recognized for its therapeutic properties, is set to play a pivotal role in the emerging trend of AI health coaches—a sector still untapped. Little DragonTM, with its pioneering AI Budtender technology, positions itself at the forefront, ready to provide cannabis consumers with the personalized wellness insights that will soon be expected across all facets of health and well-being, heralding a new era with generative AI. 

 

Competition

 

Business Model

Our business model unfolds through a strategic three-phase approach designed for growth and scalability. Phase 1 lays the foundation with the development of our advanced virtual budtender technology, leveraging machine learning and AI, alongside launching Little Dragon-branded cannabis products that set a new industry standard. We aim to complete our API development within 90 days of the close of our seed round. Phase 2 shifts our attention to monetization, launching our API on California-based delivery service platforms, and bringing revenue streams through product sales, backed by our commitment to tech support, marketing, and customer experience. The final stage, Phase 3 aims for expansion, growing our presence and licensing our technology to partners in other regions, both domestic and international. 

Team

Ross Franklin, CEO of Xiao Long Holdings, Inc. (dba “Little Dragon™”) has dedicated over a decade to pushing the envelope in the cannabis industry. As the co-inventor of a pioneering cannabis infusion technology, he secured seven USPTO-approved patents, laying the groundwork for a successful cannabis brand. His hands-on leadership and strategic foresight led the brand to an acquisition, solidifying his reputation as a disruptive force in the cannabis marketplace.